Rare diseases
Investigational molecules
Locations
5000 Belanger Street, H1T 1C8
The Montreal Heart Institute is involved in research focused on reducing cardiovascular events in adults with type 2 diabetes who have not yet experienced prior cardiovascular disease. Its clinical activity in this area centers on prevention of major complications such as myocardial infarction, stroke, and cardiac arrest.
The institute’s research interest extends to strategies aimed at limiting urgent coronary revascularization and other serious ischaemic complications in high-risk metabolic populations.
Montreal Heart Institute runs clinical trials in conditions such as Cardiovascular disorder, Myocardial infarction, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Denmark
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
